[go: up one dir, main page]

NO982497D0 - Vaksine-sammensetninger for inntak gjennom nesen - Google Patents

Vaksine-sammensetninger for inntak gjennom nesen

Info

Publication number
NO982497D0
NO982497D0 NO982497A NO982497A NO982497D0 NO 982497 D0 NO982497 D0 NO 982497D0 NO 982497 A NO982497 A NO 982497A NO 982497 A NO982497 A NO 982497A NO 982497 D0 NO982497 D0 NO 982497D0
Authority
NO
Norway
Prior art keywords
ingestion
nose
vaccine compositions
compositions
chitosan
Prior art date
Application number
NO982497A
Other languages
English (en)
Other versions
NO982497L (no
NO323084B1 (no
Inventor
Lisbeth Illum
Original Assignee
Danbiosyst Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danbiosyst Uk Ltd filed Critical Danbiosyst Uk Ltd
Publication of NO982497L publication Critical patent/NO982497L/no
Publication of NO982497D0 publication Critical patent/NO982497D0/no
Publication of NO323084B1 publication Critical patent/NO323084B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19982497A 1995-12-07 1998-06-02 Vaksine-sammensetninger NO323084B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9525083.3A GB9525083D0 (en) 1995-12-07 1995-12-07 Vaccine compositions
PCT/GB1996/003019 WO1997020576A1 (en) 1995-12-07 1996-12-09 Vaccine compositions for intranasal administration comprising chitosan and use thereof

Publications (3)

Publication Number Publication Date
NO982497L NO982497L (no) 1998-06-02
NO982497D0 true NO982497D0 (no) 1998-06-02
NO323084B1 NO323084B1 (no) 2006-12-27

Family

ID=10785093

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19982497A NO323084B1 (no) 1995-12-07 1998-06-02 Vaksine-sammensetninger

Country Status (13)

Country Link
US (2) US6391318B1 (no)
EP (1) EP0865297B1 (no)
JP (1) JP4063876B2 (no)
AT (1) ATE227134T1 (no)
CA (1) CA2237529C (no)
DE (1) DE69624726T2 (no)
DK (1) DK0865297T3 (no)
ES (1) ES2186809T3 (no)
GB (2) GB9525083D0 (no)
NO (1) NO323084B1 (no)
NZ (1) NZ323973A (no)
PT (1) PT865297E (no)
WO (1) WO1997020576A1 (no)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9419979D0 (en) * 1994-10-04 1994-11-16 Medeva Holdings Bv Vaccine compositions
US5993852A (en) * 1997-08-29 1999-11-30 Pharmaderm Laboratories Ltd. Biphasic lipid vesicle composition for transdermal administration of an immunogen
GB9725084D0 (en) 1997-11-28 1998-01-28 Medeva Europ Ltd Vaccine compositions
US7022683B1 (en) * 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
EP1163001A2 (en) * 1999-03-24 2001-12-19 The Secretary of State for Defence Vaccine composition
GB9914412D0 (en) * 1999-06-22 1999-08-18 Worrall Eric E Method for the preservation of viruses,bacteria and biomolecules
US20030206958A1 (en) * 2000-12-22 2003-11-06 Cattaneo Maurizio V. Chitosan biopolymer for the topical delivery of active agents
EP1315672A4 (en) 2000-06-22 2006-04-26 Rxkinetix Inc ADMINISTRATIVE COMPOSITION COMPOSITION AND METHOD FOR THE ADMINISTRATION OF ANTIGENES AND OTHER ACTIVE SUBSTANCES
WO2002034287A2 (en) * 2000-10-27 2002-05-02 Pharmexa A/S Therapeutic vaccine formulations containing chitosan
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US6777000B2 (en) * 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
CA2457027C (en) 2001-08-16 2011-10-11 Medical Research Council Chitin microparticles and their medical uses
CN100333792C (zh) 2001-09-28 2007-08-29 南佛罗里达大学 Rsv基因表达疫苗
MXPA04004730A (es) * 2001-11-19 2004-07-30 Becton Dickinson Co Composiciones farmaceuticas en forma particulada.
GB0302218D0 (en) * 2003-01-30 2003-03-05 Chiron Sri Vaccine formulation & Mucosal delivery
WO2003094960A2 (en) * 2002-05-14 2003-11-20 Chiron Srl Mucosal combination vaccines for bacterial meningitis
DE60328481D1 (de) * 2002-05-14 2009-09-03 Novartis Vaccines & Diagnostic Schleimhautapplizierter impfstoff, der das adjuvanz chitosan und menigokokkenantigene enthält
JP2005537244A (ja) * 2002-06-28 2005-12-08 ナステック・ファーマシューティカル・カンパニー・インコーポレーテッド 療法化合物の粘膜搬送を増進させるための、上皮接合部接着分子の生理機能を調節する組成物および方法
JP2006516609A (ja) * 2003-01-30 2006-07-06 カイロン ソチエタ ア レスポンサビリタ リミタータ 粘膜髄膜炎菌性ワクチン
ATE426412T1 (de) * 2003-01-30 2009-04-15 Novartis Vaccines & Diagnostic Adjuvante influenza-vakzine
EP1594547A2 (en) 2003-02-14 2005-11-16 University Of South Florida Research Foundation, Inc. Chitosan-microparticles for ifn gene delivery
WO2004076664A2 (en) * 2003-02-21 2004-09-10 University Of South Florida Vectors for regulating gene expression
US20040253211A1 (en) * 2003-04-30 2004-12-16 Nastech Pharmaceutical Company Inc. Method for diagnosing and treating cancer
JP2006525354A (ja) * 2003-05-01 2006-11-09 アルキメデス・ディヴェロップメント・リミテッド Ｌｈ−ｒｈアナログロイプロイドの経鼻投与
US8008255B2 (en) 2003-05-30 2011-08-30 Amylin Pharmaceuticals, Inc. Methods and compositions for enhanced transmucosal delivery of peptides and proteins
GB0315632D0 (en) * 2003-07-04 2003-08-13 West Pharm Serv Drug Res Ltd Pharmaceutical formulations
WO2005056021A1 (en) 2003-12-04 2005-06-23 University Of South Florida Polynucleotides for reducing respiratory syncytial virus gene expression
US7968122B2 (en) * 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
US20050129679A1 (en) * 2003-12-15 2005-06-16 Nastech Pharmaceutical Company Inc. Method for opening tight junctions
US7740883B2 (en) * 2004-03-28 2010-06-22 University Of Debrecen Nanoparticles from chitosan
WO2005107710A2 (en) * 2004-05-06 2005-11-17 Ivrea Pharmaceuticals, Inc. Particles for the delivery of active agents
US20090069226A1 (en) * 2004-05-28 2009-03-12 Amylin Pharmaceuticals, Inc. Transmucosal delivery of peptides and proteins
US20050283004A1 (en) * 2004-06-18 2005-12-22 Hopax Chemicals Manufacturing Co., Ltd. Alkylsulfonated polyaminosaccharides
CA2577336A1 (en) * 2004-09-15 2006-03-23 Otsuka Pharmaceutical Co., Ltd. Permucosal composition and method of improving permucosal absorption
WO2007086923A2 (en) * 2005-05-23 2007-08-02 University Of South Florida Controlled and sustained gene transfer mediated by thiol-modified polymers
US20100272769A1 (en) * 2005-08-03 2010-10-28 Amcol International Virus-, Bacteria-, and Fungi-Interacting Layered Phyllosilicates and Methods of Use
US20080184618A1 (en) * 2005-08-03 2008-08-07 Amcol International Virus-Interacting Layered Phyllosilicates and Methods of Use
US20070031512A1 (en) * 2005-08-03 2007-02-08 Amcol International Corporation Virus-interacting layered phyllosilicates and methods of inactivating viruses
US8536324B2 (en) * 2005-10-21 2013-09-17 University Of South Florida Method of drug delivery by carbon nanotube-chitosan nanocomplexes
WO2007059605A1 (en) * 2005-11-04 2007-05-31 Bio Syntech Canada Inc. Composition and method for efficient delivery of nucleic acids to cells using chitosan
WO2007064755A2 (en) 2005-11-30 2007-06-07 Endo Pharmaceuticals Inc. Treatment of xerostomia with a sulfur-containing antioxidant
AU2007285472B2 (en) * 2006-03-30 2013-10-24 Engene, Inc. Non-viral compositions and methods for transfecting gut cells in vivo
CN101472598A (zh) 2006-06-20 2009-07-01 Cmp医疗有限公司 包含壳多糖微粒的组合物及其医药用途
DK2066354T3 (da) 2006-09-29 2013-05-27 Ligocyte Pharmaceuticals Inc Norovirus vaccine formuleringer
EP2112923A1 (en) 2007-01-22 2009-11-04 Targacept Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
US20080182819A1 (en) * 2007-01-29 2008-07-31 Act Iii Licensing, Llc Chitosan compositions and methods for using chitosan compositions in the treatment of health disorders
CA2688111A1 (en) 2007-05-23 2008-12-04 Amcol International Corporation Cholesterol-interacting layered phyllosilicates and methods of reducing hypercholesteremia in a mammal
CN104740624B (zh) 2007-09-18 2018-04-24 武田疫苗股份有限公司 赋予针对诺如病毒的保护性免疫应答的疫苗
US20100266636A1 (en) 2007-09-18 2010-10-21 Ligocyte Pharmaceuticals, Inc. Method of conferring a protective immune response to norovirus
EP2818178A1 (en) * 2008-01-11 2014-12-31 The Government of The United States of America as represented by The Secretary, Department of Health and Human Services Polypeptide vaccine and vaccination strategy against mycobacterium
EP2257173B1 (en) 2008-02-27 2014-07-30 Amcol International Corporation Protonated hydrogen ion-exchanged layered phyllosilicate material for use in treating atherosclerosis
SG2013057732A (en) * 2008-08-08 2015-02-27 Ligocyte Pharmaceuticals Inc Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
EP2419132B1 (en) * 2009-04-15 2014-06-25 Ceva Sante Animale Recombinant avian herpes virus vectors and vaccine for immunizing waterfowl species
MY170746A (en) 2011-07-11 2019-08-27 Takeda Vaccines Inc Parenteral norovirus vaccine formulations
WO2013163337A1 (en) 2012-04-24 2013-10-31 The Ohio State University Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
US10279028B2 (en) 2012-04-24 2019-05-07 Ohio State Innovation Foundation Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
CN108715607B (zh) * 2018-04-12 2021-12-10 华南农业大学 重组霍乱毒素b亚基蛋白、pedv灭活疫苗及制备与应用
CN109172817B (zh) * 2018-08-16 2021-10-26 华中农业大学 猪流行性腹泻病毒减毒活疫苗壳聚糖微球的制备方法及其应用
EP3698773A1 (en) 2019-02-21 2020-08-26 Università degli Studi di Parma Composition and manufacturing of powders containing nanoadjuvants for mucosal vaccination

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1261264A (en) * 1984-11-29 1989-09-26 Shigeo Suzuki Immunopotentiating agents and method
US4950740A (en) * 1987-03-17 1990-08-21 Cetus Corporation Recombinant diphtheria vaccines
GB8904370D0 (en) * 1989-02-25 1989-04-12 Cosmas Damian Ltd Liquid delivery compositions
US5554388A (en) * 1989-02-25 1996-09-10 Danbiosyst Uk Limited Systemic drug delivery compositions comprising a polycationi substance
GB9202464D0 (en) * 1992-02-05 1992-03-18 Danbiosyst Uk Composition for nasal administration
EP0789590B1 (en) 1994-09-23 2002-09-04 Zonagen, Inc. Chitosan induced immunopotentiation
US5912000A (en) * 1994-09-23 1999-06-15 Zonagen, Inc. Chitosan induced immunopotentiation
GB9419979D0 (en) 1994-10-04 1994-11-16 Medeva Holdings Bv Vaccine compositions
CA2219904A1 (en) * 1995-06-26 1997-01-16 Research Triangle Pharmaceuticals, Ltd. Novel adjuvant compositions and vaccine formulations comprising same
GB9522351D0 (en) * 1995-11-01 1996-01-03 Medeva Holdings Bv Vaccine compositions

Also Published As

Publication number Publication date
DK0865297T3 (da) 2003-03-03
US20030039665A1 (en) 2003-02-27
NO982497L (no) 1998-06-02
GB9811810D0 (en) 1998-07-29
ATE227134T1 (de) 2002-11-15
DE69624726D1 (de) 2002-12-12
GB9525083D0 (en) 1996-02-07
AU705452B2 (en) 1999-05-20
NZ323973A (en) 2004-12-24
DE69624726T2 (de) 2003-09-18
WO1997020576A1 (en) 1997-06-12
CA2237529A1 (en) 1997-06-12
EP0865297B1 (en) 2002-11-06
ES2186809T3 (es) 2003-05-16
GB2322801B (en) 2000-01-19
JP2000501412A (ja) 2000-02-08
US6391318B1 (en) 2002-05-21
PT865297E (pt) 2003-03-31
JP4063876B2 (ja) 2008-03-19
US7323183B2 (en) 2008-01-29
NO323084B1 (no) 2006-12-27
AU1102597A (en) 1997-06-27
CA2237529C (en) 2008-10-14
EP0865297A1 (en) 1998-09-23
GB2322801A (en) 1998-09-09

Similar Documents

Publication Publication Date Title
NO982497L (no) Vaksine-sammensetninger for inntak gjennom nesen
ES2140076T3 (es) Vacunas que contienen una saponina y un esterol.
NO20002741L (no) Vaksine-blandinger omfattende kitosan, for mukosal administrasjon
NO991524L (no) Vaksiner
FI972945A0 (fi) Antigeenien antamiseen soveltuvia koostumuksia
NO981963D0 (no) Influensavaksine-blandinger
TR200002855T2 (tr) Raloksifenin solunum yolu ile veya burundan uygulanması.
DE60210456D1 (de) Solubisierung von kapseln polysacchariden
DK0745387T3 (da) Adjuvanser til virale vacciner
ES2182914T3 (es) Inmunopotenciacion inducida de quitosan.
UY24654A1 (es) Composición de vacuna contra la malaria
WO1998040097A3 (en) Bovine respiratory and enteric coronavirus as a vaccine
HUP9801572A2 (hu) Chlamydia-vakcinák
WO1999057278A3 (en) IMMUNIZATION AGAINST AND TREATMENT FOR INFECTION BY $i(H.PYLORI)
ATE329615T1 (de) Borrelia burgdorferi bacterin
ES2082221T3 (es) Neuraminidasa y galactosa-oxidasa en calidad de adyuvante de vacunas.
SE9604322D0 (sv) Bacterial antigens and vaccine compositions II
SE9301831D0 (sv) Pharmaceutical compositions
NZ316110A (en) vaccine containing an antigen from H. Influenzae and an antigen from influenza virus
ECSP961731A (es) Vacunas
AR244552A1 (es) Procedimiento para la preparacion de una composicion de aplicacion en veterinaria, que incluye una vacuna y un inmunoestimulante como amplificador de la respuesta inmunologica de dicha vacuna.
HUP9902885A1 (hu) Maláriaellenes vakcinakészítmények

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees